Monday, 24 February 2025 03:30 PM
Class Action
NEW YORK CITY, NY / ACCESS Newswire / February 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of United Health Group Incorporated ("UnitedHealth" or the "Company") (NYSE:UNH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether UnitedHealth and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On February 21, 2025, the Wall Street Journal published an article reporting that the U.S. Department of Justice ("DOJ") was investigating UnitedHealth's Medicare billing practices. According to the article, the DOJ probe aims to examine the Company's practices for documenting diagnoses that trigger extra payments to its Medicare Advantage plans.
On this news, UnitedHealth's stock price fell $36.00 per share, or 7.17%, to close at $466.42 per share on February 21, 2025.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Pomerantz LLP